Page last updated: 2024-09-03

ginsenoside rh2 and betulinic acid

ginsenoside rh2 has been researched along with betulinic acid in 2 studies

Compound Research Comparison

Studies
(ginsenoside rh2)
Trials
(ginsenoside rh2)
Recent Studies (post-2010)
(ginsenoside rh2)
Studies
(betulinic acid)
Trials
(betulinic acid)
Recent Studies (post-2010) (betulinic acid)
29512001,0251676

Protein Interaction Comparison

ProteinTaxonomyginsenoside rh2 (IC50)betulinic acid (IC50)
Ubiquitin-like modifier activating enzyme 2Homo sapiens (human)11.2
SUMO1 activating enzyme subunit 1Homo sapiens (human)11.2
SUMO-conjugating enzyme UBC9Homo sapiens (human)11.2
Aldo-keto reductase family 1 member B10Homo sapiens (human)2
DNA polymerase betaRattus norvegicus (Norway rat)6.5
Tyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)1.5
5'-nucleotidaseHomo sapiens (human)7.28
Non-structural protein 1 Dengue virus1.7

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Fang, X; Guo, X; He, K; Jin, YH; Li, Q; Li, Y; Sun, C; Wang, X; Zhan, Z1
Cai, N; Jin, X; Yang, Q; Zhang, Z1

Other Studies

2 other study(ies) available for ginsenoside rh2 and betulinic acid

ArticleYear
Co-treatment with ginsenoside Rh2 and betulinic acid synergistically induces apoptosis in human cancer cells in association with enhanced capsase-8 activation, bax translocation, and cytochrome c release.
    Molecular carcinogenesis, 2011, Volume: 50, Issue:10

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Betulinic Acid; BH3 Interacting Domain Death Agonist Protein; Blotting, Western; Caspase 3; Caspase 8; Caspase 9; Cell Line, Tumor; Cell Survival; Cytochromes c; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Activation; Flow Cytometry; Ginsenosides; HeLa Cells; Hep G2 Cells; Humans; Molecular Structure; Neoplasms; Pentacyclic Triterpenes; Poly(ADP-ribose) Polymerases; Protein Transport; RNA Interference; Triterpenes

2011
A cocktail of betulinic acid, parthenolide, honokiol and ginsenoside Rh2 in liposome systems for lung cancer treatment.
    Nanomedicine (London, England), 2020, Volume: 15, Issue:1

    Topics: A549 Cells; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Betulinic Acid; Biphenyl Compounds; Cell Proliferation; Cisplatin; Ginsenosides; Humans; Lignans; Liposomes; Lung Neoplasms; Mice; Neoplasm Invasiveness; Pentacyclic Triterpenes; Sesquiterpenes; Triterpenes; Xenograft Model Antitumor Assays

2020